(+)-JNJ-A07 - HY-139602
Nur noch %1 verfügbar
Catalog #
HY-139602
Ab
492,00 €
(+)-JNJ-A07 is a highly potent, orally active pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction. (+)-JNJ-A07 exerts nanomolar to picomolar activity against a panel of 21 clinical isolates. (+)-JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-139602/plus-JNJ-A07-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | COVID-19-anti-virus |
| CAS | 2135640-93-4 |
| Storage | -20°C, 3 years (Powder) |
| MWT | 578.96 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Pathway | Anti-infection |
| Target | Dengue virus;Flavivirus;Virus Protease |
| Application: | COVID-19-anti-virus |
|---|